Brief: Vicore Pharma Q1 EBIT SEK -91.5 Million
06/05/2025 07:00
May 06 (Reuters) - Vicore Pharma Q1 adjusted free cash flow SEK -86.1 million. Q1 sales SEK 900 thousand Q1 adjusted EPS SEK -0.48 Q1 net income SEK -111.5 million Q1 cash & investments SEK 1,048.8 million
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2